The patient is waiting
We are scientists, researchers, biotechnologists, physicians, and businesspeople working to bring new medicines to market. Faster. Because we know this isn't about us. It's about the millions of patients waiting to benefit from our discoveries.
Co-founded in 1994 by Garo Armen and Pramod Srivastava as Antigenics,
our company has outgrown its name but never its raison d'être: to develop and
commercialize breakthrough immunotherapies for cancer and infectious diseases.
Today we’re reaching far beyond antigens and discovering new ways to speed our
progress. Because we know the patient is waiting.
At today’s Agenus (Nasdaq: AGEN), now more than ever before, we are inspired by
the power of ideas, by the application of science, and by the deep convictions and
commitment we share with our growing circle of partners and collaborators.
We invite you to join us.